We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

BD Completes Diabetes Care Business Spinoff to Focus on Core Business

By HospiMedica International staff writers
Posted on 04 Apr 2022
Print article
Image: BD Nano 2nd Gen Pen Needles (Photo courtesy of Embecta Corp.)
Image: BD Nano 2nd Gen Pen Needles (Photo courtesy of Embecta Corp.)

Becton, Dickinson and Company (BD Franklin Lakes, NJ, USA) has completed its spinoff of Embecta Corp. (Franklin Lakes, NJ, USA), which holds BD's former Diabetes Care business and is now one of the largest pure-play diabetes management companies in the world.

The spinoff of embecta is part of BD's 2025 strategy, which includes its three strategic pillars of Grow, Simplify and Empower. The strategic rationale for the spinoff was to create two, independent companies with attractive long-term value for BD shareholders and enhanced strategic, operational and financial characteristics. Each company will focus on its core business and product portfolios, with BD maintaining its positions across its BD Medical, BD Life Sciences and BD Interventional segments. As a producer of diabetes injection devices, embecta will focus on investing in both organic and inorganic growth opportunities and improving the lives of people living with diabetes.

"The completion of this spinoff is a significant achievement for both BD and embecta," said Tom Polen, chairman, CEO and president of BD. "While BD is proud of its heritage in the diabetes care category, we are just as excited to see our legacy advanced by embecta as a newly independent, publicly-traded corporation. Moving forward, each of our organizations will be able to focus on investment and innovation in our respective core businesses, support our customers and the patients they serve, drive strategic growth and enhance long-term shareholder value."

Related Links:
Becton, Dickinson and Company 
Embecta Corp. 


Print article
Radcal

Channels

AI

view channel
Image: ‘Hologram patients’ developed to help train doctors and nurses (Photo courtesy of University of Cambridge)

Life-Like Hologram Patients Train Doctors for Real-Time Decision Making in Emergencies

A medical training project using 'mixed reality' technology aims to make consistent, high-level and relevant clinical training more accessible across the world. University of Cambridge (Cambridge, UK)... Read more

Critical Care

view channel
Image: New device could provide alternative to opioids and other highly addictive drugs (Photo courtesy of Northwestern University)

Dissolving Implantable Device Can Manage Post-Operative Pain Without Drugs

Researchers have developed a small, soft, flexible implant that relieves pain on demand without the use of drugs. The first-of-its-kind device could provide a much-needed alternative to opioids and other... Read more

Surgical Techniques

view channel
Image: The Senhance surgical system with digital laparoscopy (Photo courtesy of Asensus Surgical)

Digital Laparoscopic Platform Leverages Augmented Intelligence and Machine Learning

Challenges in laparoscopic surgery can impact cost, utilization, effectiveness, and outcomes of the procedure. For instance, the inability of the surgeon to control vision can create efficiency and safety... Read more

Patient Care

view channel
Image: The biomolecular film can be picked up with tweezers and placed onto a wound (Photo courtesy of TUM)

Biomolecular Wound Healing Film Adheres to Sensitive Tissue and Releases Active Ingredients

Conventional bandages may be very effective for treating smaller skin abrasions, but things get more difficult when it comes to soft-tissue injuries such as on the tongue or on sensitive surfaces like... Read more

Health IT

view channel
Image: AI can reveal a patient`s heart health (Photo courtesy of Mayo Clinic)

AI Trained for Specific Vocal Biomarkers Could Accurately Predict Coronary Artery Disease

Earlier studies have examined the use of voice analysis for identifying voice markers associated with coronary artery disease (CAD) and heart failure. Other research groups have explored the use of similar... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.